Why Sanofi’s Fair Value Was Trimmed Sanofi’s fair value has been adjusted from about €104.87 to roughly €102.77, a small trim ...

The FDA expanded the approval of Cablivi to include pediatric patients 12 years and older with acquired thrombotic thrombocytopenic purpura.

Background: Pediatric primary immune thrombocytopenia (ITP) is an autoimmune disorder characterized by isolated thrombocytopenia and an increased risk of bleeding. Conventional therapies, while ...

The first GLP-1 pill for obesity, semaglutide (Wegovy) tablets from drugmaker Novo Nordisk, launched in the U.S. ( CNBC) ...

The treatment for acquired thrombotic thrombocytopenic purpura, a rare blood disorder that causes blood clots in the small ...

Luckily for us, George Clooney found an incredibly clever workaround when he nabbed his star-making role as Dr. Doug Ross on ...

Jo McIntyre, founder of TTPNetwork and a former domestic abuse reduction coordinator, has been awarded the British Empire Medal (BEM) in the King’s New Year Honours. The award recognises her 28 years ...

CRISPR Therapeutics (NASDAQ:CRSP) is one of the best emerging technology stocks to invest in. On December 22, CRISPR Therapeutics released a comprehensive clinical update on zugocaptagene geleucel ...

Sanofi (SNYNF) announced an update on their ongoing clinical study.

Novel treatment targets BTK through multi-immune modulation to help address the underlying causes of ITP Approval based on the LUNA 3 phase 3 study that demonstrated rapid and durable platelet ...